Merck
CN
Search Within
Document Type

213-188-6

Applied Filters:
Keyword:'213-188-6'
Showing 1-25 of 25 results for "213-188-6" within Technical Documents
Quality Control Ranges: MILLIPLEX® MAP Mouse Cytokine/Chemokine Panel
196 pg/mL IL-6 Control 1 97 - 201 pg/mL LIX Control 1 109 - 226 pg/mL Control 2 550 - 1143 pg/mL Control 2 513 - 1065 pg/mL Control 2 531
Quality Control Ranges: MILLIPLEX® MAP Human Cytokine/ Chemokine Magnetic Bead Panel
Control 2 600 – 1245 pg/mL Control 2 535 – 1112 pg/mL GM-CSF Control 1 91 – 188 pg/mL IL-6 Control 1 96
Quality Control Range Sheet- MTH17-112 and MTH17-212
593 – 1231 pg/mL Control 2 206 – 428 pg/mL Control 2 2079 – 4318 pg/mL IL-6 Control 1 91 – 188 pg/mL IL-15
Quality Control Range Sheet- A60MG-105 and A60MG-205
IL-6 Control 1 22 - 46 pg/mL IL-27 Control1 485 - 1008 pg/ml Control 2 107 - 223 pg/mL Control 2 2519 - 5231 pg/ml
XP725 Antibody Number-Lot Number 071M4826
254 255 256 277 278 279 280 3.5 209 210 211 212 233 234 235 236 257 258 259 260 281 282 283 284 3.6 213 214 215 216 237 238 239 240 261 262 263 264 285 286 287 288 4.1 289
Product Information Sheet - P2277
(1977). 6. Lin, Y.M. et al., J. Biol. Chem., vol. 249, 4943 (1974). 7. Crouch, T. H. et al., Biochem., vol 19, 3692-3698 (1980). 8. Klee, C. and Vanaman, T., Adv. Protein Chem., 35, 213-321 (1982
User Guide - SCC310-370
SCC355 ht-213-CA 36 F Colon Ascending Normal margin to UC SCC356 ht-213-CD 36 F Colon Descending Normal margin to UC SCC357 ht-213-CT 36 F Colon Transcending Normal margin to UC SCC358 ht-213-D 36 F Duodenum
Product Information - CSAA1
Clone:PK-G4 P8083 Signal Transduction M n/d n/d y 212 PKD P3987 Signal Transduction P y y n/d 213 Map Kinase Phosphatase-1 (MKP-1) M3787 Signal Transduction P y n/d n/d 214 Protein phosphatase 1α
Research Article: MCP-1, KC-like and IL-8 as critical mediators of
canine babesiosis is associated with a consumptive coagulopathy. Veterinary Journal. 2013; 196(2):213–7. 48. Mackness B, Hine D, Liu YF, Mastorikou M, Mackness M. Paraoxonase-1 inhibits oxidised LDL-induced
User Guide Equinox SOP Software 2.1 for Windows XP
estándar (SOP) — 213 3. Aparece la siguiente ventana: 4. Escribir el título del SOP a duplicar. 5. Modificar, si es necesario, el comentario del SOP a
inNovations Newsletter #14
L., Simon, M. I., and Shizuya, H. (1996) Genomics 34, 213–218. 5. Szybalski, W., Wild, J., and Hradecna, Z. (1999) US Patent No. 5,874,259. 6. Wild, J., Hradecna, Z., and Szybalski, W. Genomic Research
3D BIOPRINTING: Printing a Brighter Future
.; Wertheim, L.; Dvir, T. Adv. Sci. 2019, 6, 1900344. (212) Qiu, K.; Haghiashtiani, G.; McAlpine, M. C. Annu. Rev. Anal. Chem. 2018, 11, 287-306. (213) Chaudhuri, O.; Cooper-White, J.; Janmey, P
3D BIOPRINTING: Printing a Brighter Future
.; Wertheim, L.; Dvir, T. Adv. Sci. 2019, 6, 1900344. (212) Qiu, K.; Haghiashtiani, G.; McAlpine, M. C. Annu. Rev. Anal. Chem. 2018, 11, 287-306. (213) Chaudhuri, O.; Cooper-White, J.; Janmey, P
XP725 Antibody List Lot 129K4831
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214
XP725 Antibody List Lot 129K4830
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214
XP725 Antibody List Lot 089K4791
Cathepsin D C0715 1509 CTSD M NP_001900.1 y n/d n/d 146 Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y 213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d 214
inNovations Newsletter #18
Service, R. F. (2001) Science 292, 187–188. 4. Brush, M. (2002) Scientist 16, 38–41. 5. Grabski, A. C., Mehler, M., and Drott, D., (2003) inNovations 17, 3–6. 6. Keleman, B. R., Klink, T. A., Behlke
XP725 Worksheet for Lot Number 071M4826
182 1 4 5 6 cMyc C3956 183 1 4 5 7 Uvomorulin ECadherin U3254 184 1 4 5 8 Uvomorulin ECadherin U3254 185 1 4 6 1 NCadherin C2542 186 1 4 6 2 NCadherin C2542 187 1 4 6 3 NCadherin C2667 188 1
Stem Cell and Specialty Cell Culture Product Guide
with the ordering process. For immediate quotes, simply contact us directly at 888-209-8870 (908-213-0500 outside the conti- nental US and Canada), fax us at 908-387-1670, or order online at www.millipore.com
List of Antibodies
18 C1399 M y n/d n/d 211 Cytokeratin peptide 19 C6930 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 M y n/d n/d 214 phospho-DAPK (pSer308) D4941
Halal Certificate
B23379 HC-23SI1J13 212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE 98%, FG W331201 A32483 HC-23SIE869 213. 3,4-DIMETHYL-1,2-CYCLOPENTADIONE 97% W326801 B59475 HC-23SIHC55 214. 3,4-HEXANEDIONE 90% W316814
Halal Certificate
B23379 HC-22SI7U34 212. 3-(METHYLTHIO)PROPYL ISOTHIOCYANATE 98%, FG W331201 A32483 HC-22SI1Z90 213. 3,4-DIMETHYL-1,2-CYCLOPENTADIONE 97% W326801 B59475 HC-22SIDD76 214. 3,4-HEXANEDIONE 90% W316814
XP725 Antibody List 013M4793
Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d 214 phospho-DAPK (pSer308) D4941
Cytoskeletal Signaling Antibodies, Reagents and Kits
.a. 1223-1290 H R IP WB Pur Rb 100 µg AB3882 Anti-phospho-mTOR (Ser2448) M WB APur Rb 100 µg 09-213 siRNA siRNA plasmid, pKD-mTOR-v4, H RNAi 5 mg 62-302 see also GβL, Raptor, Rheb, Sin1 and
XP725 Antibody List
Cytokeratin peptide 19 C6930 3880 KRT19 NP_002267.2 M y n/d n/d 212 Pan Cytokeratin P2871 M y y y 213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d 214 phospho-DAPK (pSer308) D4941